Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Top Cited Papers
- 1 May 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 396 (2-3) , 141-149
- https://doi.org/10.1016/s0014-2999(00)00211-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Delta-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expressionInternational Journal of Immunopharmacology, 1998
- CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULESAnnual Review of Immunology, 1997
- Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune SystemToxicology and Applied Pharmacology, 1997
- Cannabinoids enhance human B‐cell growth at low nanomolar concentrationsFEBS Letters, 1995
- Signals and signs for lymphocyte responsesCell, 1994
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulatorsInternational Journal of Immunopharmacology, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse originsInternational Journal of Immunopharmacology, 1992
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogeneCell, 1991